Trends in the epidemiology of Candida bloodstream infections in Northern Ireland between January 1984 and December 2000

Journal of Infection

Volumn 45, Issue 1, 2002, Pages 25-28

  McMullan, R ^a   McClurg, R ^a   Xu, J ^a   Moore, J E ^a   Millar, B C ^a   Crowe, M ^a   Hedderwick, S ^b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; AGED; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; DATA ANALYSIS; FEMALE; FUNGEMIA; FUNGUS ISOLATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SURGICAL WARD; TEACHING HOSPITAL; UNITED KINGDOM;

EID: 0036665270     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2002.0999     Document Type: Article

References (14)

1. Weber DJ, Rutala WA, Samsa GP, Wilson MB, Hoffmann KK. Relative frequency of nosocomial pathogens at a university hospital during the decade 1980 to 1989. Am J Infect Control 1992; 20(4): 192-197.
2. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9: 499-511.
3. Pfaller MA, Jones RN, Doern GV et al. International surveillance of bloodstream infections due to Candida species in the European SENTRY Program. Diag Microbiol Infect Dis 1999; 35(1): 19-25.
4. Weinberger M, Sacks T, Sulkes J, Shapiro M, Polacheck I. Increasing fungal isolation from clinical specimens: experience in a university hospital over a decade. J Hosp Infect 1997; 35(3): 185-195.
5. Voss A, Kluytmans JA, Koeleman JG et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch University hospitals. Eur J Clin Microbiol Infect Dis 1996; 15(12): 909-912.
6. Krcmery V Jr, Kovacicova G. Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Diag Microbiol Infect Dis 2000; 36(1): 7-11.
7. Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R. Trends and sources of nosocomial fungaemia. Mycoses 1994; 37 (5-6): 187-190.
8. Pfaller MA, Messer SA, Hollis RJ et al. Trends in species distribution and susceptibility to fluconazole among bloodstream isolates of Candida species in the United States. Diag Microbiol Infect Dis 1999; 33(4): 217-222.
9. Fraser VJ, Jones M. Candidaemia in a tertiary care hospital: epidemiology risk factors and predictors of mortality. Clin Infect Dis 1992; 15: 414-421.
10. Morrison AJ Jr, Freer CV. Nosocomial bloodstream infections: secular trends in a statewide surveillance program in Virginia. Infect Control 1980; 7: 550-553.
11. Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs and modes of transmission. Clin Infect Dis 1996; 22(Suppl 2): S89-S94.
12. Banerjee SN, Emori TG, Culver DH et al. Secular trends in nosocomial primary bloodstream infections in the United States. Am J Med 1991; 91(Suppl): 86-89.
13. Chen YC, Chang SC. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan. Infect Control Hosp Epidemiol 1997; 18: 369-375.
14. Beck Sague CM, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States 1980-1990. J Infect Dis 1993; 167: 1247-1251.